-
Mashup Score: 12Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML - 2 month(s) ago
Individual donor-KIR and recipient-HLA interactions were not associated with outcomes of MUD HCT for AML.Three prevalent donor KIR genotypes were differentially
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Circulating microbial cell–free DNA is increased during neutropenia after hematopoietic stem cell transplantation - 6 month(s) ago
Key Points. mcfDNA is increased during neutropenia after allo-HCT.Studying the taxa-of-origin of this circulating DNA may provide novel insights into post-HCT b
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0With limited funding, researchers move forward on bioartificial kidneys, xenotransplants - 7 month(s) ago
In a recent editorial, Beatrice Concepcion, MD, wrote despite some challenges, transplantation “remains the treatment of choice for most patients with advanced kidney disease,” offering a better quality of life compared with dialysis.Administrators of the Medicare End-Stage Renal Disease Program see kidney transplants as more cost effective compared with dialysis and encourage the
Source: www.healio.comCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0
Accept Cookies & Privacy Policy? This website uses cookies to ensure the best possible web experience. By continuing and using the site, you consent to the use of cookies. If you wish to disable them or to learn more about how we use cookies, please view our Cookies Policy. …
Source: www.ishlt.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6
Author links open overlay panel Yue Wu 1, Michael Dymock 2, Ryan Gately 3, Julie A. Marsh 2 4, Carmel Hawley 3, Germaine Wong 1 5, Thomas L. Snelling 1 2 6 7
Source: www.sciencedirect.comCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 1
Clinical Transplantation is an international transplantation journal publishing the latest research surrounding organ and tissue transplant surgery.
Source: onlinelibrary.wiley.comCategories: Gastroenterology, Latest HeadlinesTweet-
Includes great graphics detailing immunosuppression complications, post liver transplant metabolic health management, vaccine management and malignancy screening 👇 https://t.co/WgW9vAh2ql #livertwitter https://t.co/DywKpGvylT
-
-
Mashup Score: 1Allogeneic haematopoietic stem-cell transplantation versus gene therapy for haemoglobinopathies - 7 month(s) ago
Timothy S Olson
Source: www.thelancet.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Phase III clinical trial of autologous CD34 + cell transplantation to accelerate fracture nonunion repair - BMC Medicine - 7 month(s) ago
Background We previously demonstrated that CD34 + cell transplantation in animals healed intractable fractures via osteogenesis and vasculogenesis; we also demonstrated the safety and efficacy of this cell therapy in an earlier phase I/II clinical trial conducted on seven patients with fracture nonunion. Herein, we present the results of a phase III clinical trial conducted to confirm the results of the previous phase studies using a larger cohort of patients. Methods CD34 + cells were mobilized via administration of granulocyte colony-stimulating factor, harvested using leukapheresis, and isolated using magnetic cell sorting. Autologous CD34 + cells were transplanted in 15 patients with tibia nonunion and 10 patients with femur nonunion, who were followed up for 52 weeks post transplantation. The main outcome was a reduction in time to heal the tibia in nonunion patients compared with that in historical control patients. We calculated the required number of patients as 15 based on the
Source: bmcmedicine.biomedcentral.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 1ASH Clinical News | American Society of Hematology - 7 month(s) ago
An analysis of 994 patients with AML shows that treatment with venetoclax plus low-intensity or intensive chemotherapy attenuates the negative prognostic impact of AML with a splicing factor mutation. Akshat Jain, MD, MPH, a pediatric hematologist at Loma Linda University School of Medicine and Children’s Hospital in California, shares a recent poem of his that was written in tribute to patients with sickle cell disease. A pooled analysis of 11 trials found that half of patients with MM who were treated
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study - 7 month(s) ago
Key Points. Haplo-HSCT results in encouraging disease-free survival despite significant hemorrhagic cystitis in the MAC arm.Early cessation of CNI is feasible i
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Three prevalent donor KIR genotypes were differentially associated with relapse risk in 1 large cohort but not in a validation group. https://t.co/o5Ayskl6kx #transplantation https://t.co/k2SfVRAVwd